Login

Consolidated Statements of Assets and Liabilities

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
ASSETS
Non-controlled/non-affiliated investments (amortized cost of $129,376 and $121,142, respectively)
Cash and cash equivalents
Interest receivable
Deferred credit facility costs
Due from affiliates
Other assets
Total assets
LIABILITIES
KeyBank Credit Facility
2028 Series A Notes, net of $420 and $0, respectively, of unamortized deferred financing costs
Management fees payable
Incentive fees payable
Contingent incentive fees payable
Interest payable
Security deposits
Due to affiliate
Directors' fees payable
Accrued expenses and other liabilities
Total liabilities
Commitments and contingencies (Note 6)
NET ASSETS
Common shares of beneficial interest, $0.001 par value, unlimited shares authorized, (6,107,167 and 6,017,855 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively)
Paid-in capital in excess of par
Distributable earnings
Total net assets
Total liabilities and net assets
NET ASSET VALUE PER SHARE

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support